Royalty Pharma plc (NASDAQ:RPRX) Q4 2025 Earnings Call Transcript February 11, 2026 Royalty Pharma plc beats earnings expectations. Reported EPS is $1.47, expectations were $1.33. Operator: Ladies and ...

AI is becoming a strategic differentiator in industrial automation; those who learn to apply it effectively will shape the ...

Q4 2025 Earnings Call February 11, 2026 7:30 AM ESTCompany ParticipantsCiaran Potts - Head of Investor RelationsAnthony P. J.

BP suspended its buyback program to prioritize deleveraging, targeting net debt reduction from $22B to $14–$18B by 2027.

DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient care, aesthetic innovation, and excellence across Southern California practicesNEW YORK and SUNSET ...

Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) ...

Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced Moxie as a strategic partner in ...

Yuri Bender is a journalist covering banking, asset management and capital markets. He has launched and edited several ...

According to MarketsandMarkets™, the Vascular Access Device Market is projected to grow from about USD 6.27 billion in 2026 to USD 8.68 ...

The Secretary of State has appointed Michael Eldridge, Lorna Parker, Justine Simons, and Ruth Willmott as Trustees of The Royal Parks Board for a term ...

Newco ALTx Therapeutics Ltd. has launched with a £12.55 million (US$17.1 million) seed round to develop inhibitors of the alternative lengthening of telomeres (ALT) pathway, by which 10% to 15% of ...

According to MarketsandMarkets, the Vascular Access Device Market is projected to grow from about USD 6.27 billion in 2026 to USD 8.68 billion ...